Antitussive Drugs
Antitussive drugs suppress the cough reflex. They are used for dry, distressing cough once the cause has been assessed, and they are harmful when cough clears sputum or protects the airway. Evidence for benefit in acute cough is weak.
Classification. Opioids (codeine, morphine, methadone, pholcodine), centrally acting non-opioids (dextromethorphan), peripheral agents (benzonatate, levodropropizine), neuromodulators (gabapentin, pregabalin, low dose amitriptyline) and P2X3 antagonists (gefapixant).
Mechanism. Opioids act on mu receptors in the medullary cough centre. Dextromethorphan acts centrally as an NMDA antagonist. Peripheral agents numb stretch receptors in the airway. Neuromodulators reduce central sensitisation in cough hypersensitivity. Gefapixant blocks ATP at P2X3 receptors on vagal C fibres.
Pharmacokinetics. Codeine is a prodrug converted to morphine by CYP2D6, so ultra-rapid metabolisers can develop toxicity and poor metabolisers gain no effect. Dextromethorphan is also cleared by CYP2D6 and inhibitors raise levels.













